Zolbetuximab for Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ILUSTRO: Phase 2 Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Clin. Cancer Res 2023 Jul 25;[EPub Ahead of Print], SJ Klempner, KW Lee, K Shitara, JP Metges, S Lonardi, DH Ilson, N Fazio, TY Kim, LY Bai, D Moran, J Yang, A Arozullah, JW Park, JJ Raizer, YJ Bang, MA ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.